Pathophysiology of acute meningitis caused by Streptococcus pneumoniae and adjunctive therapy approaches

Tatiana Barichello1, Jaqueline S Generoso, Allan Collodel

  • 1Laboratório de Microbiologia Experimental, Instituto Nacional de Ciência e Tecnologia Translacional em Medicina, Universidade do Extremo Sul Catarinense, Criciúma, SC, Brazil. tba@unesc.net

Insights

Pneumococcal meningitis, caused by Streptococcus pneumoniae, triggers a severe inflammatory response. This immune overreaction damages the brain, leading to oxidative stress and potentially fatal neurological sequelae.

Area of Science:

  • Neuroscience
  • Immunology
  • Infectious Diseases

Background:

  • Pneumococcal meningitis is a severe infection of the brain's protective layers.
  • The host's inflammatory response is a major contributor to disease severity and neurological damage.
  • Streptococcus pneumoniae invades the central nervous system after initial colonization and bacteremia.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying brain cell injury in pneumococcal meningitis.
  • To understand the role of the host immune response in the pathogenesis of the disease.

Main Methods:

  • Review of the inflammatory and immune pathways involved in pneumococcal meningitis.
  • Analysis of molecular events leading to oxidative stress and cell damage in the brain.

Main Results:

  • Streptococcus pneumoniae triggers immune cells via Toll-like receptors, activating key inflammatory pathways (NF-κB, MAPK).
  • Activated brain cells release pro-inflammatory mediators, attracting polymorphonuclear cells.
  • This leads to the production of reactive oxygen and nitrogen species, causing oxidative stress, lipid peroxidation, and mitochondrial damage.

Conclusions:

  • The intense inflammatory response and subsequent oxidative stress are critical drivers of brain injury in pneumococcal meningitis.
  • Damage to the blood-brain barrier and neuronal cells results from this cascade, contributing to severe neurological sequelae.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: